1 / 1

Supplemental Figure 3

Supplemental Figure 3. B. A. NS. NS. control -shRNA. TLR2 -shRNA. control -shRNA. TLR2 -shRNA. MDS-A (low-risk). MDS-B (high-risk).

lois
Télécharger la présentation

Supplemental Figure 3

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplemental Figure 3 B A NS NS control -shRNA TLR2 -shRNA control -shRNA TLR2 -shRNA MDS-A (low-risk) MDS-B (high-risk) Figure S3. Inhibition of TLR2 in primary MDS BM CD34+ cells. (a) Q-PCR analysis of TLR2 RNA expression after transduction of shRNA into two primary MDS BM CD34+ cells. (b) Methocult medium supported colony formation assays revealed no significant difference for the formation of CFU-G/M or CFU-E in BM CD34+ cells of higher-risk MDS (intermediate-2 and high-risk) two weeks after transduction of TLR2-shRNA and control shRNA.

More Related